The survival and prognosis analysis of synovial sarcoma subtypes: a Surveillance, Epidemiology, and End Results population-based analysis

被引:0
作者
Liang Xiong
Zhuoyuan Chen
You Zhou
Hui Li
Tao Xiao
机构
[1] The Second Xiangya Hospital of Central South University,Department of Orthopedics
[2] Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province,undefined
[3] Orthopedic Biomedical Materials Institute of Central South University,undefined
来源
International Orthopaedics | 2020年 / 44卷
关键词
Synovial sarcoma; Subtypes; Prognosis; Tumors; SEER database;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2779 / 2786
页数:7
相关论文
共 73 条
[1]  
Han I(2018)Deep learning approach for survival prediction for patients with synovial sarcoma Tumour Biol J Int Soc Oncodev Biol Med 40 1010428318799264-1027
[2]  
Kim JH(2007)Synovial sarcoma: clinicopathologic features, treatment, and prognosis Orthopedics 30 1020-1739
[3]  
Park H(2017)Histology and grading are important prognostic factors in synovial sarcoma Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 43 1733-2607
[4]  
Siegel HJ(1999)Synovial sarcoma: identification of low and high risk groups Cancer 85 2596-3547
[5]  
Sessions W(2009)Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients Cancer 115 3537-79
[6]  
Casillas MAJ(2013)Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes Ann Surg Oncol 20 73-598
[7]  
Bianchi G(2018)Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas Clin Orthop Relat Res 476 589-433
[8]  
Sambri A(2016)The incidence and survival of rare cancers of the thyroid, parathyroid, adrenal, and pancreas Ann Surg Oncol 23 424-2230
[9]  
Righi A(2019)Epidemiology, incidence, and survival of rhabdomyosarcoma subtypes: SEER and ICES database analysis J Orthop Res Off Publ Orthop Res Soc 37 2226-322
[10]  
Bergh P(2015)Synovial sarcoma diagnosis and management in the era of targeted therapies Curr Opin Oncol 27 316-164